Abrocitinib 200 mg

Janus Kinase Inhibition in Granuloma Annulare

Janus Kinase Inhibition in Sarcoidosis

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India